Exact FDA event identifier

Event 93202

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 17, 2023
Product types: Drug
Classifications: Class III
Statuses: Ongoing
Recalling firm wording: AbbVie Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

D-0088-2024

Recall number: D-0088-2024
Initiated: October 17, 2023
Classification: Class III
Status: Ongoing
Recalling firm: AbbVie Inc.
Quantity: 864 cartons

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0

Labeling: Wrong

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Code information

Lot # 1187435 exp date: 02/2024

Distribution pattern

Distributed in the US. No government or foreign consignees.